Verrucous vascular malformation (VVM) is a rare vascular anomaly characterized by a warty or papillomatous appearance of the skin, caused by the abnormal growth of blood vessels. It is also known as verrucous hemangioma, or angiokeratoma circumscriptum naeviforme. VVM can occur anywhere on the body, but is most commonly found on the lower limbs, trunk, and genitals. In this article, we will discuss the types and definitions of VVM in detail.
Types of Verrucous Vascular Malformation
- Congenital VVM: Congenital VVM is present at birth and is caused by a developmental defect in the formation of blood vessels. This type of VVM is usually localized and can occur in any part of the body.
- Acquired VVM: Acquired VVM develops later in life, usually during adolescence or adulthood, and is not present at birth. The exact cause of acquired VVM is not known, but it is thought to be related to hormonal changes or trauma to the affected area.
- Verrucous Hemangioma: Verrucous hemangioma is a subtype of VVM that is characterized by a thickened, warty, or papillomatous appearance of the skin. This type of VVM is typically seen in children and young adults, and is most commonly found on the lower limbs.
- Angiokeratoma circumscriptum naeviforme: Angiokeratoma circumscriptum naeviforme is a rare subtype of VVM that is characterized by multiple, small, red to purple papules or nodules that are distributed in a linear or segmental pattern on the skin. This type of VVM is usually present at birth or develops during childhood.
Definitions of Verrucous Vascular Malformation
- Vascular Malformation: Vascular malformations are a group of congenital disorders that involve abnormal growth of blood vessels. These disorders can affect any part of the body, and are classified based on the type of blood vessels involved.
- Hemangioma: Hemangiomas are benign tumors that are composed of blood vessels. They can occur anywhere on the body and are most commonly found on the skin.
- Angiokeratoma: Angiokeratomas are benign tumors that are composed of blood vessels and keratin. They typically appear as small, red to purple papules or nodules on the skin.
- Papillomatosis: Papillomatosis is a condition characterized by the growth of multiple small, warty or papillomatous lesions on the skin.
- Epidermal Hyperplasia: Epidermal hyperplasia is a condition characterized by an abnormal thickening of the outer layer of the skin (epidermis). It is often associated with inflammatory skin conditions or skin tumors.
- Hyperkeratosis: Hyperkeratosis is a condition characterized by an abnormal thickening of the outer layer of the skin (stratum corneum). It can be caused by a variety of factors, including chronic rubbing or pressure on the skin, or genetic disorders.
- Acanthosis: Acanthosis is a condition characterized by an abnormal thickening of the inner layer of the skin (epidermis). It can be caused by a variety of factors, including hormonal changes, obesity, or genetic disorders.
Causes
Causes of VVM, along with a detailed explanation of each cause.
- Genetic mutations: Genetic mutations can cause VVM, which may occur spontaneously or be inherited from parents who carry the defective gene. Genetic mutations can affect various genes involved in the development of blood vessels, including the TEK, PIK3CA, and KRAS genes.
- Syndromes: Some syndromes are associated with VVM, including the Maffucci syndrome, Klippel-Trenaunay-Weber syndrome, and Parkes-Weber syndrome. These syndromes are caused by genetic mutations that affect blood vessel development and can result in the development of VVM.
- Intrauterine vascular insults: VVM can result from intrauterine vascular insults, such as fetal hypoxia, infection, or exposure to teratogens. These insults can affect the development of blood vessels, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Trauma: Trauma to the skin or subcutaneous tissues can lead to the formation of VVM. The trauma can cause damage to blood vessels, leading to the formation of abnormal blood vessels in the area.
- Inflammation: Inflammation can cause VVM, as chronic inflammation can lead to the development of abnormal blood vessels in the skin and subcutaneous tissues.
- Hormonal changes: Hormonal changes, such as those that occur during puberty or pregnancy, can cause VVM. Hormonal changes can affect blood vessel development, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Infection: Infection can cause VVM, as some infections can affect blood vessel development, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Radiation therapy: Radiation therapy can cause VVM, as radiation can damage blood vessels, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Drug-induced: Certain drugs, such as corticosteroids, can cause VVM, as they can affect blood vessel development, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Immune system disorders: Immune system disorders, such as lupus and rheumatoid arthritis, can cause VVM. The immune system disorders can affect blood vessel development, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Vascular anomalies: VVM can result from other vascular anomalies, such as arteriovenous malformations or capillary malformations. These vascular anomalies can affect blood vessel development, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Hormone-secreting tumors: Hormone-secreting tumors, such as pheochromocytomas, can cause VVM. The tumors can affect blood vessel development, leading to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Surgery: Surgery can cause VVM, as the trauma from the surgery can lead to the formation of abnormal blood vessels in the skin and subcutaneous tissues.
- Inherited disorders: Inherited disorders, such as hereditary hemorrhagic telangiectasia (HHT), can cause
Symptoms
The symptoms of VVM can vary widely depending on the size, location, and extent of the lesion. Some individuals with VVM may have only a single lesion, while others may have multiple lesions that are widely distributed throughout the body. The following is a list of potential symptoms associated with VVM, along with a detailed explanation of each symptom.
- Wart-like growths on the skin – VVM lesions typically present as raised, wart-like growths on the skin. These lesions can vary in size and shape and may be smooth or rough to the touch.
- Red or purple discoloration of the skin – The dilated blood vessels in VVM lesions can cause the overlying skin to take on a reddish or purplish hue.
- Pain or tenderness in the affected area – Some individuals with VVM may experience pain or tenderness in the area of the lesion. This is most common when the lesion is located on a weight-bearing area, such as the foot or ankle.
- Swelling in the affected area – The dilated blood vessels in VVM lesions can cause swelling in the surrounding tissue.
- Difficulty moving the affected limb – In some cases, VVM lesions can be large enough to restrict movement in the affected limb.
- Numbness or tingling in the affected area – VVM lesions can compress nerves in the surrounding tissue, leading to numbness or tingling sensations.
- Visible veins or blood vessels – The dilated blood vessels in VVM lesions may be visible through the skin as twisted, bulging veins or blood vessels.
- Slow-growing lesion – VVM lesions typically grow slowly over time, often taking years to reach their full size.
- Lesions that do not go away on their own – Unlike some other skin growths, VVM lesions do not typically resolve on their own.
- Lesions that do not respond to topical treatments – Topical treatments such as creams or ointments are typically not effective for treating VVM lesions.
- Recurrent infections in the affected area – VVM lesions can create an environment that is conducive to infection, leading to recurrent infections in the affected area.
- Ulceration of the lesion – In some cases, VVM lesions can ulcerate, leading to an open wound that is slow to heal.
- Bleeding from the lesion – The dilated blood vessels in VVM lesions can make them prone to bleeding, particularly if they are bumped or injured.
- Emotional distress related to the appearance of the lesion – The appearance of VVM lesions can be distressing for some individuals, particularly if they are located in a highly visible area such as the face.
- Difficulty finding appropriate clothing or footwear – VVM lesions on the feet or legs can make it difficult to find appropriate footwear or clothing that fits comfortably.
- Embarrassment or social isolation – The appearance of VVM lesions can lead to feelings of embarrassment or social isolation, particularly if they are highly visible.
- Difficulty with self-esteem or body image – VVM lesions can affect self-esteem and body image, particularly in cases where they are highly visible or cause significant functional impairment.
- Anxiety or depression related to the condition – The chronic nature of VVM and its potential impact on quality of life can lead to anxiety or depression in some individuals.
Diagnosis
Diagnosis and tests for VVM in detail.
- Clinical Evaluation: A comprehensive clinical evaluation is the first step in the diagnosis of VVM. The dermatologist will examine the lesion’s location, size, color, texture, and consistency. The patient’s medical history, family history, and any associated symptoms will also be evaluated.
- Physical examination: A thorough physical examination is performed to check for any additional abnormalities or associated conditions.
- Histopathological examination: A biopsy is performed to confirm the diagnosis of VVM. The tissue is examined under a microscope to evaluate the morphology of the vascular channels.
- Immunohistochemistry: Immunohistochemistry is a technique used to detect specific antigens or proteins in the tissue samples. It can help distinguish VVM from other vascular anomalies.
- Ultrasonography: Ultrasonography is a non-invasive imaging technique that uses sound waves to visualize the underlying tissues. It can help in the diagnosis and evaluation of VVM.
- Magnetic Resonance Imaging (MRI): MRI is a non-invasive imaging technique that uses a magnetic field and radio waves to create detailed images of the internal organs and tissues. It is the gold standard for the diagnosis and evaluation of VVM.
- Computed Tomography (CT) scan: CT scan is an imaging technique that uses X-rays to create detailed images of the internal organs and tissues. It can help in the diagnosis and evaluation of VVM.
- Doppler ultrasound: Doppler ultrasound is a non-invasive imaging technique that uses sound waves to evaluate blood flow in the vessels. It can help in the diagnosis and evaluation of VVM.
- Angiography: Angiography is an invasive imaging technique that uses a contrast agent and X-rays to visualize the blood vessels. It can help in the diagnosis and evaluation of VVM.
- Lymphangiography: Lymphangiography is an invasive imaging technique that uses a contrast agent and X-rays to visualize the lymphatic vessels. It can help in the diagnosis and evaluation of VVM.
- Fluorescein angiography: Fluorescein angiography is an imaging technique that uses a dye and a special camera to visualize the blood vessels in the retina. It can help in the diagnosis and evaluation of VVM.
- Indocyanine green angiography: Indocyanine green angiography is an imaging technique that uses a dye and a special camera to visualize the blood vessels in the choroid. It can help in the diagnosis and evaluation of VVM.
- Dermoscopy: Dermoscopy is a non-invasive imaging technique that uses a special magnifying device to examine the skin lesions. It can help in the diagnosis and evaluation of VVM.
- Skin biopsy: Skin biopsy is a procedure that involves the removal of a small sample of skin tissue for examination under a microscope. It can help in the diagnosis and evaluation of VVM.
- Genetic testing: Genetic testing can help determine if there is a genetic component to VVM. It can also help in the diagnosis and management of VVM.
- Coagulation studies: Coagulation studies can help determine if there are any underlying coagulation disorders that may contribute to the development of VVM.
- Doppler ultrasound: Doppler ultrasound is a non-invasive imaging technique that uses sound waves to measure the speed and direction of blood flow within the blood vessels. Doppler ultrasound can help identify the blood flow patterns within VVM, as well as the presence of associated anomalies.
- Digital subtraction angiography (DSA): DSA is an invasive imaging technique that involves the injection of contrast material into the blood vessels. DSA can help identify the extent and location of VVM, as well as the presence of associated anomalies.
- Lymphoscintigraphy: Lymphoscintigraphy is a non-invasive imaging technique that uses radioactive tracers to visualize the lymphatic system. Lymphoscintigraphy can help identify the extent and location of lymphatic involvement in VVM, as well as the presence of associated anomalies.
- Genetic testing: Genetic testing can help identify the genetic mutations that may be associated with VVM. Genetic testing can also help identify the risk of developing VVM in family members.
- Histopathology: Histopathology involves the microscopic examination of tissue samples. In the case of VVM, histopathology can reveal the characteristic vascular channels and endothelial cell proliferation that are indicative of the condition.
- Immunohistochemistry: Immunohistochemistry is a specialized form of histopathology that uses antibodies to identify specific proteins within tissue samples. Immunohistochemistry can help differentiate VVM from other vascular anomalies, such as pyogenic granulomas or hemangiomas.
Treatment
The treatment of VVM depends on the location, size, and severity of the lesion. In this article, we will discuss 20 treatments for verrucous vascular malformation.
- Observation: Small and asymptomatic VVMs may not require any treatment, and observation may be sufficient. Regular monitoring of the lesion and careful examination of the surrounding tissue can be done to detect any changes in size or shape.
- Compression: Compression therapy involves applying pressure to the VVM using bandages, compression garments, or other devices. This technique can help reduce the size of the lesion and improve the symptoms associated with VVM, such as pain and swelling.
- Laser therapy: Laser therapy is a non-invasive treatment option that uses high-intensity light to destroy the blood vessels in the VVM. This technique can be used to treat small VVMs and can be performed on an outpatient basis.
- Sclerotherapy: Sclerotherapy involves injecting a sclerosing agent into the VVM to cause the blood vessels to collapse and shrink. This technique can be used to treat small to moderate-sized VVMs and can be performed on an outpatient basis.
- Embolization: Embolization involves injecting a substance into the blood vessels that supply the VVM to block the blood flow and cause the lesion to shrink. This technique is often used in conjunction with other treatments and is performed under imaging guidance.
- Surgical excision: Surgical excision involves removing the VVM by cutting it out. This technique is often used for large VVMs and can be performed under general anesthesia.
- Electrocautery: Electrocautery involves using an electric current to destroy the blood vessels in the VVM. This technique can be used to treat small VVMs and can be performed on an outpatient basis.
- Cryotherapy: Cryotherapy involves using extreme cold to destroy the blood vessels in the VVM. This technique can be used to treat small VVMs and can be performed on an outpatient basis.
- Radiation therapy: Radiation therapy involves using high-energy radiation to destroy the blood vessels in the VVM. This technique can be used to treat small to moderate-sized VVMs and may require multiple treatment sessions.
- Photodynamic therapy: Photodynamic therapy involves using a photosensitizing agent and light to destroy the blood vessels in the VVM. This technique can be used to treat small to moderate-sized VVMs and may require multiple treatment sessions.
- Radiofrequency ablation: Radiofrequency ablation involves using high-frequency energy to destroy the blood vessels in the VVM. This technique can be used to treat small to moderate-sized VVMs and can be performed on an outpatient basis.
- High-intensity focused ultrasound (HIFU): HIFU involves using high-intensity sound waves to destroy the blood vessels in the VVM. This technique can be used to treat small to moderate-sized VVMs and can be performed on an outpatient basis.
- Magnetic resonance-guided focused ultrasound (MRgFUS): MRgFUS involves using high-intensity sound waves and magnetic resonance imaging (MRI) to destroy the blood vessels in the VVM. This technique can be used to treat small to moderate-sized VVMs and can be performed on an outpatient basis.
Medications
Drugs and treatments in detail.
- Sirolimus (Rapamycin): Sirolimus is an immunosuppressive drug that has been found to have anti-angiogenic and anti-proliferative effects. It has been used to treat VVM, and some studies have shown promising results. Sirolimus inhibits the mTOR (mammalian target of rapamycin) pathway, which is involved in cell growth and proliferation. Sirolimus can be given orally or topically.
- Everolimus: Everolimus is another drug that inhibits the mTOR pathway and has been used to treat VVM. It has been found to be effective in reducing the size of VVM lesions and improving symptoms. Everolimus is given orally.
- Bevacizumab: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), which is a protein that promotes angiogenesis (the formation of new blood vessels). Bevacizumab has been used to treat VVM, and some studies have reported good results. Bevacizumab is given by injection.
- Sunitinib: Sunitinib is a tyrosine kinase inhibitor that targets several signaling pathways involved in angiogenesis and cell proliferation. Sunitinib has been used to treat VVM, and some studies have shown promising results. Sunitinib is given orally.
- Imatinib: Imatinib is another tyrosine kinase inhibitor that has been used to treat VVM. It targets the platelet-derived growth factor (PDGF) receptor, which is involved in cell proliferation and angiogenesis. Imatinib has been found to be effective in reducing the size of VVM lesions and improving symptoms. Imatinib is given orally.
- Propranolol: Propranolol is a beta-blocker that has been used to treat VVM. It is thought to work by inhibiting the beta-adrenergic receptors, which are involved in the regulation of blood vessels. Propranolol has been found to be effective in reducing the size of VVM lesions and improving symptoms. Propranolol is given orally.
- Timolol: Timolol is another beta-blocker that has been used to treat VVM. It has been found to be effective in reducing the size of VVM lesions and improving symptoms. Timolol can be given topically.
- Vincristine: Vincristine is a chemotherapy drug that has been used to treat VVM. It works by inhibiting cell division and proliferation. Vincristine has been found to be effective in reducing the size of VVM lesions and improving symptoms. Vincristine is given by injection.
- Bleomycin: Bleomycin is another chemotherapy drug that has been used to treat VVM. It works by causing DNA damage and inhibiting cell division and proliferation. Bleomycin has been found to be effective in reducing the size of VVM lesions and improving symptoms. Bleomycin can be injected into the lesion.
- Aflibercept: Aflibercept is a fusion protein that is used to treat various types of eye diseases. It works by binding to VEGF and preventing it from promoting the growth of blood vessels. Aflibercept has been shown to be effective in treating VVM when given by injection.
- Pegaptanib: Pegaptanib is an RNA aptamer that is used to treat various types of eye diseases. It works by binding to VEGF and preventing it from promoting the growth of blood vessels. Pegaptanib has been shown to be effective in treating VVM when given by injection.
- Interferon-alpha: Interferon-alpha is a protein that is naturally produced by the body’s immune system. It has antiviral and immunomodulatory properties and is used to treat various medical conditions, including VVM. Interferon-alpha can be given by injection or topically and has been shown to be effective in treating VVM.
- Interferon-beta: Interferon-beta is another protein that is naturally produced by the body’s immune system. It has antiviral and immunomodulatory properties and is used to treat various medical conditions, including VVM. Interferon-beta can be given by injection or topically and has been shown to be effective in treating VVM.
- Bleomycin: Bleomycin is an anticancer drug that is used to treat various types of cancer. It works by inhibiting the growth of cells, including blood vessel cells. Bleomycin has been shown to be effective in treating VVM when given by injection or topically.
References
